Categories: News

BioSyent Schedules Q4 and Full Year 2020 Earnings Release for March 17, 2021

MISSISSAUGA, Ontario, March 11, 2021 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended December 31, 2020 on Wednesday, March 17, 2021. A presentation on the Company’s fourth quarter and full year 2020 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release.

About BioSyent Inc.

Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty and international business units.

As of the date of this press release, the Company has 12,740,775 common shares outstanding.

For a direct market quote for the TSX Venture Exchange and other Company financial information please visit www.tmxmoney.com.

For further information please contact:

Mr. René C. Goehrum
President and CEO
BioSyent Inc.
E-Mail: investors@biosyent.com
Phone: 905-206-0013
Web: www.biosyent.com

Staff

Recent Posts

Nurse Practitioners Secure No. 1 Spot Across Three U.S. News & World Report Best Jobs Rankings

Profession Ranks #1 for Best Job, Best Health Care Job and Best STEM Job AUSTIN,…

2 hours ago

A Groundbreaking Forum at HIMSS25 Focused on Behavioral Health

LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- Informa Connect announces a landmark collaboration with Behavioral…

2 hours ago

Purina Awards $125,000 to Five U.S.-Based Pet Startups through 2025 Pet Care Innovation Prize

Winning startups across the pet industry – from veterinary care to treats and e-commerce –…

2 hours ago

Data Innovations Appoints New President and CEO, Eric Dingfelder

COLCHESTER, Vt., Jan. 15, 2025 /PRNewswire/ -- Leading lab middleware company Data Innovations, LLC, has…

2 hours ago

Accelerated Cure Project for MS and EMD Serono Partner to Provide Resources to Caregivers

WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Accelerated Cure Project (ACP) for Multiple Sclerosis (MS)…

2 hours ago